Morgan Stanley Call 12 DVAX 20.09.../ DE000ME9SK66 /
| 14/06/2024 18:54:15 | Chg.- | Bid09:36:36 | Ask09:36:36 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.800EUR | - | 0.710 Bid Size: 1,500 |
- Ask Size: - |
Dynavax Technologies... | 12.00 USD | 20/09/2024 | Call |
GlobeNewswire
15/05
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
06/03
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Va...
GlobeNewswire
08/01
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical O...
GlobeNewswire
01/03/2022
Valneva Receives Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA20...
GlobeNewswire
25/02/2022
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate V...
GlobeNewswire
25/01/2022
Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine Candidate
GlobeNewswire
19/01/2022
Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
GlobeNewswire
06/01/2022
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vac...
GlobeNewswire
23/12/2021
Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site
GlobeNewswire
16/12/2021
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted COVID-19 Vaccine Cand...
GlobeNewswire
08/12/2021
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001
GlobeNewswire
02/12/2021
Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine ...
GlobeNewswire
29/11/2021
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2...
GlobeNewswire
23/11/2021
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA20...
GlobeNewswire
10/11/2021
Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million D...
GlobeNewswire
04/11/2021
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
GlobeNewswire
02/11/2021
Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
GlobeNewswire
18/10/2021
Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2...
GlobeNewswire
23/09/2021
Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001
GlobeNewswire
14/09/2021
Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 V...
GlobeNewswire
13/09/2021
Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government
